Isotechnika Pharma Inc IPHAF

RE: Short report/ Part 3

[stockman6]

Here's another post from Teevee on shorting ISA. I especially like the following words of wisdom from the esteemed Bay Street drunk: "Nobody makes big (short) bets against a purported "block buster" drug, unless they know something that the street hasn't tuned into yet." That's right Teevee, "NOBODY". P.S. What rhymes with "hypocrate". ---------------------------------------------------------------- The last news release indicates short positions are increasing-that is what the title of my post referred to. Evidently, I just didn't make it clear enough. The recent pattern of trading suggests to me that the size of the short postion is getting even larger as retail buys come in on the upticks. I thought that the article I posted was particularily timely, given the nature of the posts lately. I do hope that cooler heads prevail on this thread, rather than the continued attacks by those who are head over heals in love with ISA. I doubt the increase in short positions is based only upon technical trading patterns and stock price history. Nobody makes big (short) bets against a purported "block buster" drug, unless they know something that the street hasn't tuned into yet. What that might be, and as important, how critical that information is, is the $64,000.00 question. Could it be only a matter of timing (ie. no phase II results until the 4th quarter 2002),or something critical to the success of ISAtx247?